vindesine has been researched along with Carcinoma, Large Cell in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asamura, H; Kodama, T; Kunitoh, H; Matsuno, Y; Ohe, Y; Saijo, N; Sekine, I; Takei, H; Tamura, T; Tsuchiya, R; Yamamoto, N; Yamazaki, S | 1 |
| Funakoshi, Y; Kadota, Y; Kawamura, S; Koma, M; Maeda, H; Matsubara, Y; Takeda, S | 1 |
| Arriagada, R; Douillard, JY; Lacombe-Terrier, MJ; Laplanche, A; Le Chevalier, T; Martin, M; Quoix, E; Ruffie, P; Tarayre, M | 1 |
| Higashino, K; Igarashi, T; Ikegami, H; Kawase, T; Komuta, K; Nakamura, S; Nakano, T; Nishikawa, H; Tachibana, T; Yokota, S; Yoshida, M | 1 |
| Bertrand, P; Bockaert, J; De Beukelaar, T; De Muynck, P; Deman, R; Mariën, S; Roex, L; Ulrichts, H; Vandebroek, J; Vansteenkiste, J | 1 |
| Haneda, H; Hayashi, T; Koizumi, M | 1 |
| Aoki, H; Fukai, S; Hashimoto, K; Hayashihara, K; Ishida, T; Kuwahara, K; Minegishi, Y; Nemoto, E; Okano, T; Saito, T; Watanabe, K; Watanabe, S; Yanai, N | 1 |
| Akira, M; Atagi, S; Hosoe, S; Kawaguchi, T; Kawahara, M; Mitsuoka, S; Naka, N; Ogawara, M; Okishio, K; Sunami, T | 1 |
5 trial(s) available for vindesine and Carcinoma, Large Cell
| Article | Year |
|---|---|
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Humans; Life Tables; Lomustine; Lung Neoplasms; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Vindesine | 1994 |
A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Time Factors; Vindesine | 1996 |
Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chi-Square Distribution; Cisplatin; Confidence Intervals; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Rate; Time Factors; Vindesine; Weight Loss | 1995 |
[An early phase II trial combining cisplatin, carboplatin and vindesine in patients with inoperable non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Vindesine | 2000 |
A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Radiation Dosage; Survival Rate; Treatment Failure; Vindesine | 2002 |
3 other study(ies) available for vindesine and Carcinoma, Large Cell
| Article | Year |
|---|---|
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Treatment Outcome; Vindesine | 2005 |
Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Empyema, Pleural; Female; Forced Expiratory Volume; Forecasting; Humans; Hypoxia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Pneumonia; Postoperative Complications; Predictive Value of Tests; Pulmonary Atelectasis; Pulmonary Diffusing Capacity; Pulmonary Embolism; Pulmonary Gas Exchange; Radiotherapy; Remission Induction; Respiratory Distress Syndrome; Respiratory Insufficiency; Retrospective Studies; Risk Factors; Vinblastine; Vindesine; Vinorelbine; Vital Capacity | 2006 |
[Effectiveness of docetaxel plus cisplatin in large cell lung cancer showing little response to prior chemotherapy with MVP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Taxoids; Treatment Failure; Vindesine | 2000 |